NewGen BioPharma Corp. Interest Receivable, Current
NewGen BioPharma Corp. had Interest Receivable, Current of $1.36 thousand as of 2017-01-31, per its 10-Q filed 2017-03-09.
Discontinued › Notes
us-gaap:InterestReceivableCurrent · last filed 2017-03-09
- 2017-01-31: Interest Receivable, Current $1.36K.
| Period end | Interest Receivable, Current |
|---|---|
| 2017-01-31 | $1.36K 10-Q · filed 2017-03-09 |